Michael B. Brenner

Advisor at Mestag Therapeutics

Prof. Brenner is the Brigham Professor of Medicine at Harvard Medical School and Director of the Human Immunology Center at Brigham and Women’s Hospital, Boston. He is co-chair of the NIH-FNIH RA/SLE Accelerating Medicines Partnership (AMP) consortium. He is a member of the National Academy of Sciences, a Fellow of the American Academy of Microbiology, and a Fellow of the American Association for the Advancement of Science. He received the Lee C. Howley Prize for Research in Arthritis (Arthritis Foundation), the Distinguished Basic Investigator Award (American College of Rheumatology), and the Carol-Nachman Prize in Rheumatology. Michael’s laboratory and The Human Immunology Center he leads, design, and implement high dimensional immunophenotyping, single-cell transcriptomic analyses, and functional studies to deconstruct human autoimmune disorders. Using a combination of single-cell technologies and functional models, his current work is defining new stromal subsets, their roles in synovial pathology, and how to target them therapeutically.

Timeline

  • Advisor

    Current role